| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,045 |
3,907 |
$233K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,077 |
1,064 |
$105K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,889 |
1,817 |
$84K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
595 |
595 |
$50K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
971 |
951 |
$50K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
391 |
391 |
$33K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,830 |
2,826 |
$26K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
293 |
285 |
$23K |
| 90461 |
|
673 |
672 |
$23K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
265 |
264 |
$22K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
231 |
231 |
$21K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,991 |
1,987 |
$21K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
419 |
417 |
$13K |
| 92552 |
|
504 |
503 |
$11K |
| 99173 |
|
410 |
410 |
$9K |
| 96127 |
|
725 |
723 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
251 |
250 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
386 |
382 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
155 |
148 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
113 |
111 |
$2K |
| 87081 |
|
292 |
288 |
$2K |
| 99050 |
|
86 |
86 |
$1K |
| 87634 |
|
15 |
15 |
$866.88 |
| 0074A |
|
12 |
12 |
$550.56 |
| 99051 |
|
32 |
32 |
$513.36 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$360.69 |
| 85018 |
|
153 |
153 |
$332.16 |
| 81003 |
|
15 |
15 |
$29.70 |